Clin2
NCT05859191Possibly a fitRecruiting

Study of immune cell markers in people with lupus

Systemic Lupus ErythematosusPhysiopathology

Treatments studied

Part of Immune system & allergy, Skin clinical trials.

This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have a definite diagnosis of systemic lupus
  • Your lupus can be newly diagnosed or you are in a relapse
  • Your healthcare team feels your condition is stable enough for participation
  • You need to have blood drawn for follow-up as part of the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07251179Recruiting
Understanding immune cells in autoimmune diseases and immune deficiencies

This study looks at immune cells in people with certain autoimmune diseases or immune deficiencies. The goal is to understand how these cells work, which may help improve future treatments.

Strasbourg
NCT06921239Recruiting
HLA antibodies in lupus patients

This study looks for certain immune markers (HLA antibodies) in stored blood samples from people with lupus. It may help doctors understand how the immune system behaves in lupus.

Amiens
NCT07780045Not yet recruiting
New blood markers for lupus kidney disease

This study looks at two simple blood tests to see if they can help doctors understand and predict how lupus-related kidney disease (lupus nephritis) is progressing. The goal is to improve monitoring and treatment decisions for people with this condition.

NCT07136337Not yet recruiting
IgG and IgM markers in lupus disease activity

This study looks at two blood markers (IgG and IgM) in people with lupus to see if they can help measure disease activity and damage. It may help doctors better understand and manage lupus.

Asyut, Asyut Governorate
NCT06462768Recruiting
Study of immune cell activity in systemic sclerosis

This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.

Reims
NCT07666711Recruiting
Kidney biomarker study for lupus patients

This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.

Oslo, Oslo

Hear when a new Systemic Lupus Erythematosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.